A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT05489991 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Study was stopped Sponsor discretion. No patients were dosed.

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

BIOLOGICAL: TmPSMA-02

Sponsor

Tceleron Therapeutics, Inc.